1-4 of 4
Shay Shemesh, MA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results from Ongoing Phase 1/2 Trial of SL-401 in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Myo Htut, MD, Cristina Gasparetto, MD, Jeffrey Zonder, MD, Thomas G. Martin, III, MD, Emma C. Scott, MD, Janice Chen, PhD, Shay Shemesh, MA, Christopher L. Brooks, PhD, Dharminder Chauhan, PhD, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Claudia E. Paba-Prada, MD
Journal: Blood
Blood (2016) 128 (22): 5696.
https://doi.org/10.1182/blood.V128.22.5696.5696
Published: 2016
Journal Articles

Results from Phase 2 Trial Ongoing Expansion Stage of SL-401 in Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Naveen Pemmaraju, MD, Andrew A. Lane, MD PhD, Kendra L. Sweet, MD, Anthony S. Stein, MD, Sumithira Vasu, MBBS, William Blum, MD, David A Rizzieri, MD, Eunice S. Wang, MD, Madeleine Duvic, MD, Janice Chen, PhD, Shay Shemesh, MA, Peter McDonald, Christopher L. Brooks, PhD, Jeffrey E. Lancet, MD, Hagop M. Kantarjian, MD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2016) 128 (22): 342.
https://doi.org/10.1182/blood.V128.22.342.342
Published: 2016
Journal Articles

Results from Ongoing Phase 2 Trial of SL-401 As Consolidation Therapy in Patients with Acute Myeloid Leukemia (AML) in Remission with High Relapse Risk Including Minimal Residual Disease (MRD)

Andrew A. Lane, MD PhD, Kendra L. Sweet, MD, Eunice S. Wang, MD, William B. Donnellan, MD, Roland B. Walter, MD PhD, Anthony S. Stein, MD, David A Rizzieri, MD, Hetty E. Carraway, MD MBA, Ioannis Mantzaris, MD, Thomas Prebet, MD PhD, Michael B. Maris, MD, Stefan Faderl, MD, Dale L. Bixby, MD PhD, Janice Chen, PhD, Ross Lindsay, PhD, Shay Shemesh, MA, Christopher L. Brooks, PhD, Richard M. Stone, MD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2016) 128 (22): 215.
https://doi.org/10.1182/blood.V128.22.215.215
Published: 2016
Journal Articles

Results from Ongoing Phase 2 Trial of SL-401 in Patients with Advanced, High-Risk Myeloproliferative Neoplasms Including Chronic Myelomonocytic Leukemia

Mrinal M Patnaik, MBBS, Vikas Gupta, MD FRCP, FRCPath, Jason R. Gotlib, MD, Hetty E. Carraway, MD MBA, Martha Wadleigh, MD, Gary J. Schiller, MD, Moshe Talpaz, MD, Cecilia Arana-Yi, MD, James K. McCloskey, MD, Sangmin Lee, MD, Abdulraheem Yacoub, MD, Haris Ali, MD, Minakshi S. Taparia, MBBS, MRCPath, Janice Chen, PhD, Shay Shemesh, MA, Christopher L. Brooks, PhD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Srdan Verstovsek, MD PhD, Naveen Pemmaraju, MD
Journal: Blood
Blood (2016) 128 (22): 4245.
https://doi.org/10.1182/blood.V128.22.4245.4245
Published: 2016